LISA ANN HILLMAN, PHARM D
Pharmacy at Kasota Ave, Minneapolis, MN
License number
Minnesota 118522
Category
Pharmacy
Type
Pharmacist
Address
Address
711 Kasota Ave SE, Minneapolis, MN 55414
Phone
(612) 672-5260
(612) 672-5262 (Fax)
(612) 972-5260
(612) 672-5262 (Fax)
(612) 972-5260
Personal information
See more information about LISA ANN HILLMAN at radaris.comName
Address
Phone
19 27Th Ave SE, Minneapolis, MN 55414
645 Birch Ave, Gibbon, MN 55335
Professional information
Abuse Resistant Drug Formulation
US Patent:
2011020, Aug 18, 2011
Filed:
Apr 27, 2011
Appl. No.:
13/095434
Inventors:
Walid Habib - Brooklyn Park MN, US
Ehab Hamed - Brooklyn Park MN, US
Derek Moe - Brooklyn Park MN, US
Carrie Kraling - Brooklyn Park MN, US
Lisa Hillman - Brooklyn Park MN, US
Ehab Hamed - Brooklyn Park MN, US
Derek Moe - Brooklyn Park MN, US
Carrie Kraling - Brooklyn Park MN, US
Lisa Hillman - Brooklyn Park MN, US
Assignee:
CIMA LABS INC. - Brooklyn Park MN
International Classification:
A61K 9/50, A61K 9/52, A61K 31/485, A61P 25/04, A61P 25/36
US Classification:
424495, 424494, 424496, 424497, 427 221, 514282
Abstract:
A pharmaceutical composition may include a granulate which may include at least one active pharmaceutical ingredient susceptible to abuse by an individual mixed with at least two materials, a first material that is substantially water insoluble and at least partially alcohol soluble and a second material that is substantially alcohol insoluble and at least partially water soluble, wherein the active pharmaceutical ingredient and the two materials are granulated in the presence of water and alcohol. The composition may also include a coating on the granulate exhibiting crush resistance which may have a material that is deposited on the granulate using an alcohol based solvent. The composition further comprises a second particle comprising a fat/wax. The present invention also includes a coated granulate, various dosage forms of the composition, as well as methods of production and tableting.
Abuse Resistant Drug Formulation
US Patent:
2013012, May 16, 2013
Filed:
Dec 31, 2012
Appl. No.:
13/731587
Inventors:
Cima Labs Inc. - Brooklyn Park MN, US
Ehab Hamed - Brooklyn Park MN, US
Derek Moe - Brooklyn Park MN, US
Carrie Kraling - Brooklyn Park MN, US
Lisa Hillman - Brooklyn Park MN, US
Ehab Hamed - Brooklyn Park MN, US
Derek Moe - Brooklyn Park MN, US
Carrie Kraling - Brooklyn Park MN, US
Lisa Hillman - Brooklyn Park MN, US
Assignee:
CIMA LABS INC. - Brooklyn Park MN
International Classification:
A61K 9/20
US Classification:
424465
Abstract:
A pharmaceutical composition may include a granulate which may include at least one active pharmaceutical ingredient susceptible to abuse by an individual mixed with at least two materials, a first material that is substantially water insoluble and at least partially alcohol soluble and a second material that is substantially alcohol insoluble and at least partially water soluble, wherein the active pharmaceutical ingredient and the two materials are granulated in the presence of water and alcohol. The composition may also include a coating on the granulate exhibiting crush resistance which may have a material that is deposited on the granulate using an alcohol based solvent. The composition further comprises a second particle comprising a fat/wax. The present invention also includes a coated granulate, various dosage forms of the composition, as well as methods of production and tableting.
Orally Dissolvable/Disintegrable Lyophilized Dosage Forms Containing Protected
US Patent:
2008003, Feb 7, 2008
Filed:
Jul 23, 2007
Appl. No.:
11/880503
Inventors:
Ehab Hamed - Maple Grove MN, US
Lisa Hillman - Brooklyn Park MN, US
Rajendra Khankari - Maple Grove MN, US
Derek Moe - Maple Grove MN, US
Thanh-Tam Nguyen - Limeil-Brevannes, FR
Lisa Hillman - Brooklyn Park MN, US
Rajendra Khankari - Maple Grove MN, US
Derek Moe - Maple Grove MN, US
Thanh-Tam Nguyen - Limeil-Brevannes, FR
Assignee:
CIMA LABS INC. - Eden Prairie MN
Cephalon France - Maisons-Alfort Cedex
Cephalon France - Maisons-Alfort Cedex
International Classification:
A61K 9/26, A61K 31/135, A61K 31/165, A61K 31/426, A61K 31/445, A61K 9/16
US Classification:
424469000, 424490000, 514315000, 514370000, 514618000, 514646000
Abstract:
The present invention provides an orally dissolvable/disintegrable, lyophilized, dosage form adapted for direct oral dosing, including an active pharmaceutical ingredient (“API”) containing particle which is coated with a lyophilizing solvent protective coating, which protects the form and/or attributes of the particle and/or API, and a matrix. There is also provided a method of making an orally dissolvable/disintegrable lyophilized dosage form in accordance with the present invention, and a method of treating a patient with a dosage form in accordance with the present invention.